Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3116317
Max Phase: Preclinical
Molecular Formula: C17H20N4O3
Molecular Weight: 328.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3116317
Max Phase: Preclinical
Molecular Formula: C17H20N4O3
Molecular Weight: 328.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)c1ccc2c(c1)nc(N)c1nc(C)n(CC(C)(C)O)c12
Standard InChI: InChI=1S/C17H20N4O3/c1-9-19-13-14(21(9)8-17(2,3)23)11-6-5-10(16(22)24-4)7-12(11)20-15(13)18/h5-7,23H,8H2,1-4H3,(H2,18,20)
Standard InChI Key: WMYKXORUYKRBKG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 328.37 | Molecular Weight (Monoisotopic): 328.1535 | AlogP: 2.03 | #Rotatable Bonds: 3 |
Polar Surface Area: 103.26 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.08 | CX LogP: 1.54 | CX LogD: 1.54 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.71 | Np Likeness Score: -0.59 |
1. Schiaffo CE, Shi C, Xiong Z, Olin M, Ohlfest JR, Aldrich CC, Ferguson DM.. (2014) Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine induction., 57 (2): [PMID:24383475] [10.1021/jm4004957] |
Source(1):